JMVYX | JVMRX | JMVYX / JVMRX | |
Total Expense Ratio | 0.60 | 0.75 | 80% |
Annual Report Gross Expense Ratio | 0.69 | 0.76 | 91% |
Fund Existence | 9 years | 14 years | - |
Gain YTD | 2.260 | 7.981 | 28% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 15000000 | 1000000 | 1,500% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.7B | 22.6B | 56% |
Annual Yield % from dividends | 1.04 | 0.88 | 118% |
Returns for 1 year | -2.44 | -1.34 | 182% |
Returns for 3 years | 6.26 | 24.48 | 26% |
Returns for 5 years | 20.04 | 57.40 | 35% |
Returns for 10 years | N/A | 46.94 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LRGC | 72.68 | 0.55 | +0.76% |
AB US Large Cap Strategic Equities ETF | |||
XTAP | 38.48 | 0.10 | +0.25% |
Innovator US Equity Acltd Pls ETF™ April | |||
LFAK | 133.71 | N/A | N/A |
LifeX 2052 Longevity Income ETF | |||
TOTL | 39.63 | -0.01 | -0.03% |
SPDR® DoubleLine® Total Return Tact ETF | |||
CURE | 74.62 | -2.63 | -3.40% |
Direxion Daily Healthcare Bull 3X ETF |